Canada · Delayed Price · Currency is CAD Extendicare Statistics
Total Valuation
Extendicare has a market cap or net worth of CAD 2.75 billion. The enterprise value is 3.27 billion.
| Market Cap | 2.75B |
| Enterprise Value | 3.27B |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Nov 30, 2026 |
Share Statistics
Extendicare has 95.05 million shares outstanding. The number of shares has increased by 8.15% in one year.
| Current Share Class | 95.05M |
| Shares Outstanding | 95.05M |
| Shares Change (YoY) | +8.15% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 1.25% |
| Owned by Institutions (%) | 43.38% |
| Float | 93.86M |
Valuation Ratios
The trailing PE ratio is 20.97 and the forward PE ratio is 17.50.
| PE Ratio | 20.97 |
| Forward PE | 17.50 |
| PS Ratio | 1.25 |
| PB Ratio | 6.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 29.14 |
| P/OCF Ratio | 18.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.77, with an EV/FCF ratio of 34.70.
| EV / Earnings | 24.48 |
| EV / Sales | 1.48 |
| EV / EBITDA | 13.77 |
| EV / EBIT | 16.76 |
| EV / FCF | 34.70 |
Financial Position
The company has a current ratio of 0.68, with a Debt / Equity ratio of 1.38.
| Current Ratio | 0.68 |
| Quick Ratio | 0.60 |
| Debt / Equity | 1.38 |
| Debt / EBITDA | 2.56 |
| Debt / FCF | 6.37 |
| Interest Coverage | 5.99 |
Financial Efficiency
Return on equity (ROE) is 44.34% and return on invested capital (ROIC) is 15.35%.
| Return on Equity (ROE) | 44.34% |
| Return on Assets (ROA) | 9.83% |
| Return on Invested Capital (ROIC) | 15.35% |
| Return on Capital Employed (ROCE) | 16.64% |
| Weighted Average Cost of Capital (WACC) | 9.10% |
| Revenue Per Employee | 92,176 |
| Profits Per Employee | 5,590 |
| Employee Count | 23,500 |
| Asset Turnover | 1.80 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Extendicare has paid 38.93 million in taxes.
| Income Tax | 38.93M |
| Effective Tax Rate | 22.86% |
Stock Price Statistics
The stock price has increased by +79.04% in the last 52 weeks. The beta is 1.08, so Extendicare's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | +79.04% |
| 50-Day Moving Average | 28.92 |
| 200-Day Moving Average | 30.14 |
| Relative Strength Index (RSI) | 57.57 |
| Average Volume (20 Days) | 521,844 |
Short Selling Information
The latest short interest is 1.59 million, so 1.90% of the outstanding shares have been sold short.
| Short Interest | 1.59M |
| Short Previous Month | 1.60M |
| Short % of Shares Out | 1.90% |
| Short % of Float | 2.22% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Extendicare had revenue of CAD 2.17 billion and earned 131.36 million in profits. Earnings per share was 1.38.
| Revenue | 2.17B |
| Gross Profit | 309.59M |
| Operating Income | 189.11M |
| Pretax Income | 170.28M |
| Net Income | 131.36M |
| EBITDA | 224.99M |
| EBIT | 189.11M |
| Earnings Per Share (EPS) | 1.38 |
Balance Sheet
The company has 75.26 million in cash and 590.39 million in debt, with a net cash position of -515.13 million or -5.42 per share.
| Cash & Cash Equivalents | 75.26M |
| Total Debt | 590.39M |
| Net Cash | -515.13M |
| Net Cash Per Share | -5.42 |
| Equity (Book Value) | 428.62M |
| Book Value Per Share | 4.51 |
| Working Capital | -124.82M |
Cash Flow
In the last 12 months, operating cash flow was 142.81 million and capital expenditures -50.14 million, giving a free cash flow of 92.67 million.
| Operating Cash Flow | 142.81M |
| Capital Expenditures | -50.14M |
| Depreciation & Amortization | 35.88M |
| Net Borrowing | 235.55M |
| Free Cash Flow | 92.67M |
| FCF Per Share | 0.97 |
Margins
Gross margin is 14.29%, with operating and profit margins of 8.73% and 6.06%.
| Gross Margin | 14.29% |
| Operating Margin | 8.73% |
| Pretax Margin | 7.86% |
| Profit Margin | 6.06% |
| EBITDA Margin | 10.39% |
| EBIT Margin | 8.73% |
| FCF Margin | 4.28% |
Dividends & Yields
This stock pays an annual dividend of 0.53, which amounts to a dividend yield of 1.83%.
| Dividend Per Share | 0.53 |
| Dividend Yield | 1.83% |
| Dividend Growth (YoY) | 5.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 36.23% |
| FCF Payout Ratio | 54.28% |
| Buyback Yield | -8.15% |
| Shareholder Yield | -6.29% |
| Earnings Yield | 4.77% |
| FCF Yield | 3.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for Extendicare is 38.94, which is 34.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 38.94 |
| Price Target Difference | 34.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 16.54% |
| EPS Growth Forecast (3Y) | 19.01% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Extendicare has an Altman Z-Score of 2.88 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.88 |
| Piotroski F-Score | 5 |